Determination of diltiazem hydrochloride enantiomers in dog plasma using chiral stationary-phase liquid chromatography

Analytical Chemistry Research Laboratory, Tanabe Seiyaku Co., Ltd., Osaka, Japan.
Journal of Chromatography A (Impact Factor: 4.17). 04/1991; 564(1):338-45. DOI: 10.1016/0378-4347(91)80100-Q
Source: PubMed


The separation and determination of d- and l-diltiazem hydrochloride in dog plasma by a two-column high-performance liquid chromatographic technique are described. Diltiazem hydrochloride and its metabolites were extracted from dog plasma and analyzed on a conventional column (Nucleosil 5C18) with a volatile buffer system. The column effluent of diltiazem hydrochloride was collected and evaporated. The enantiomeric ratio of the collected diltiazem was determined using a chiral column (Chiralcel OC). The method was accurate and sensitive.

4 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Pharmaceutical enantiomers often exhibit different pharmacodynamic and pharmacokinetic properties. Stereospecific chromatographic assays are available to separate these stereoisomers. Therapeutic agents often contain chemical functional groups (e.g. amino, hydroxyl, carbonyl, and carboxylic acid). These can be reacted with enantiomerically pure reagents to give diastereoisomers suitable for analysis on achiral gas chromatographic (GC) and high performance liquid chromatographic (HPLC) columns. Alternatively, derivatized or underivatized drugs may be resolved on chiral chromatographic phases. A wide variety of GC (e.g. amino acid, cyclodextrin, and metal-complex) and HPLC (mobile phase additive, crown ether, pi-pi interaction and related phases, protein, cyclodextrin, polysaccharide, methacrylate and amide polymer, and ligand exchange) columns are commercially available. This article reviews the chromatographic separation of enantiomers.
    The Journal of Clinical Pharmacology 10/1992; 32(10):917-24. DOI:10.1002/j.1552-4604.1992.tb04639.x · 2.48 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A direct enantiomeric separation of diltiazem hydrochloride and its related compounds was investigated by using an ovomucoid bonded chiral stationary phase. The enantiomers of diltiazem hydrochloride, the 8-chloro derivative of diltiazem (clentiazem maleate) and their desacetyl forms were resolved with a mobile phase of acetonitrile-0.02 M phosphate buffer (pH 6.0) according to the retention mechanism of reversed-phase liquid chromatography. The effects of mobile phase composition on the retention and the enantioselectivity, the effects of sample capacity on the retention time, theoretical plate number, peak height and peak area were investigated. The chromatographic conditions chosen for the separation permitted the separation of these enantiomers within 20 min. The determination of the antipode in the drug substances and those in tablets was also successfully achieved at levels down to ca. 0.1% by the area-percentage method.
    Journal of Chromatography A 02/1993; 633(1-2):89-96. DOI:10.1016/0021-9673(93)83141-E · 4.17 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A method is proposed for the direct enantiomeric separation of cis-(+/-)diltiazem in plasma. The method is based on a commercial Ultron ES-OVM column with a mobile phase of different mixtures of ethanol-phosphate buffer. The degree of extraction of the enantiomers was more than 86%. The detection limit of the method used was 5 ng of racemic mixture on column (coefficient of variation = 13%), corresponding to 3.2 ng for cis-(+/-)diltiazem and 1.8 ng for cis-(+/-)diltiazem.
    Journal of Chromatography A 10/1993; 619(1):87-92. DOI:10.1016/0378-4347(93)80449-E · 4.17 Impact Factor
Show more

Similar Publications